Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04257045 · ClinicalTrials.gov registry record

Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives

A clinical trial, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
46
Enrollment target

NCT04257045: Completed study, sponsored by M.D. Anderson Cancer Center.

NCT04257045 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 46 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04257045 has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
46 participants
Enrollment target

Study Summary

This trial collects information about factors that affect communication of genetic test results, decision-making, and access to genetic testing in women with hereditary gynecological cancers. Studying individuals who are positive for a genetic mutation and immediate biological family members (including a parent, full-sibling, or child) may help identify cancer genes and other persons at risk.

Interventions

  • OTHER Survey Administration
  • OTHER Questionnaire Administration
  • OTHER Interview

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2019-08-21
Est. Completion 2024-07-09

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT04257045

The ClinicalTrials.gov registry entry for NCT04257045 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Survey Administration is the first listed.

NCT04257045 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04257045 about?

NCT04257045 is a clinical study titled "Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives". This trial collects information about factors that affect communication of genetic test results, decision-making, and access to genetic testing in women with hereditary gynecological cancers. Studying individuals who are positive for a genetic mutation and immediate biological family members (includ...

What is the current status of trial NCT04257045?

This trial is currently completed. The enrollment target is 46 participants. The study started on 2019-08-21. Estimated completion is 2024-07-09.

What interventions are being tested in trial NCT04257045?

The interventions under investigation include: Survey Administration (OTHER), Questionnaire Administration (OTHER), Interview (OTHER).

Who is sponsoring clinical trial NCT04257045?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.